Results 161 to 170 of about 7,007,953 (262)

Research progress on BTG2 in non‑tumor diseases (Review). [PDF]

open access: yesInt J Mol Med
Li S   +5 more
europepmc   +1 more source

Deciphering the circadian signature in acute myeloid leukemia: NPAS2 downregulation as a master predictive feature. [PDF]

open access: yesBlood Res
da Cunha LS   +13 more
europepmc   +1 more source

Disulfidptosis: molecular mechanisms and therapeutic targets. [PDF]

open access: yesSignal Transduct Target Ther
Wang C   +6 more
europepmc   +1 more source

Epigenetic Dysregulation of Somatostatin Receptors (SSTR) 1–5 and Therapeutic Implications in Neuroendocrine and Non‐Neuroendocrine Malignancies

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Somatostatin receptors (SSTR) mediate the antiproliferative, antisecretory, and proapoptotic effects of somatostatin and its synthetic analogs. Their surface expression on neuroendocrine tumor (NET) cells is required for somatostatin analog therapy and radiopharmaceutical therapy (RPT).
Neeraj Kumari   +10 more
wiley   +1 more source

Neoplastic CD3⁺ B cells remodel the DLBCL tumor microenvironment via single-cell and spatial transcriptomics. [PDF]

open access: yesCancer Biol Ther
Lang M   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy